Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma

Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma

Background: Hepatocellular carcinoma (HCC) accounts for more than 75% of primary liver cancers, which are the second leading cause of cancer-related deaths. The GALAD (gender, age, AFP-L3, AFP, and des-carboxy-prothrombin) score is a diagnostic tool developed based on gender, age, alpha-fetoprotein,...

Full description

Bibliographic Details
Main Authors: Silvia Cagnin, Rossella Donghia, Andrea Martini, Pasqua Letizia Pesole, Sergio Coletta, Endrit Shahini, Giulia Boninsegna, Alessandra Biasiolo, Patrizia Pontisso, Gianluigi Giannelli
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:International Journal of Molecular Sciences
Subjects:
hepatocellular carcinoma
GALAD
prognosis
biomarker
Online Access:https://www.mdpi.com/1422-0067/24/22/16485

Internet

https://www.mdpi.com/1422-0067/24/22/16485

Similar Items